alpha-amanitin has been researched along with Disease Models, Animal in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 3 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Anderl, J; Ellis, LM; Han, C; He, X; Huang, X; Ivan, C; Jiang, D; Liu, Y; Lopez-Berestein, G; Lu, X; Maru, DM; Pahl, A; Rao, PH; Rodriguez-Aguayo, C; Sood, AK; Wan, G; Zhang, X | 1 |
| Cander, B; Çolak, T; Dündar, ZD; Ergin, M; Kilinç, İ; Oltulu, P | 1 |
| Diewold, A; Hawerkamp, E; Klingert, W; Königsrainer, A; Lauber, J; Morgalla, MH; Schenk, M; Scheppach, J; Scheuermann, K; Thiel, C; Thiel, K | 1 |
3 other study(ies) available for alpha-amanitin and Disease Models, Animal
| Article | Year |
|---|---|
TP53 loss creates therapeutic vulnerability in colorectal cancer.
Topics: Alpha-Amanitin; Animals; Antibodies; Antigens, Neoplasm; Catalytic Domain; Cell Adhesion Molecules; Cell Line, Tumor; Cell Proliferation; Colorectal Neoplasms; Databases, Genetic; Disease Models, Animal; Epithelial Cell Adhesion Molecule; Female; Gene Deletion; Gene Dosage; Genes, p53; Humans; Immunoconjugates; Mice; Protein Subunits; RNA Polymerase II; Tumor Suppressor Protein p53; Xenograft Model Antitumor Assays | 2015 |
The role of oxidative stress in α-amanitin-induced hepatotoxicityin an experimental mouse model.
Topics: Alpha-Amanitin; Animals; Chemical and Drug Induced Liver Injury; Disease Models, Animal; Glutathione Peroxidase; Liver; Male; Malondialdehyde; Mice; Mice, Inbred BALB C; Oxidative Stress | 2017 |
The enterohepatic circulation of amanitin: kinetics and therapeutical implications.
Topics: Alpha-Amanitin; Amanitins; Animals; Aspartate Aminotransferases; Disease Models, Animal; Enterohepatic Circulation; Female; Histocytochemistry; Liver Failure, Acute; Prothrombin Time; Swine | 2011 |